{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T09:40:03Z","timestamp":1780393203143,"version":"3.54.1"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2017,6,14]],"date-time":"2017-06-14T00:00:00Z","timestamp":1497398400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Oncol"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1007\/s10147-017-1152-8","type":"journal-article","created":{"date-parts":[[2017,6,14]],"date-time":"2017-06-14T10:59:25Z","timestamp":1497437965000},"page":"1009-1014","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Gemcitabine monotherapy in patients with heavily treated nasopharyngeal cancer: a case series"],"prefix":"10.1007","volume":"22","author":[{"given":"Tomohiro","family":"Enokida","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinya","family":"Uozumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takao","family":"Fujisawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuri","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susumu","family":"Okano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Tahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,6,14]]},"reference":[{"key":"1152_CR1","doi-asserted-by":"crossref","first-page":"E359","DOI":"10.1002\/ijc.29210","volume":"136","author":"J Ferlay","year":"2015","unstructured":"Ferlay J, Soerjomataram I, Dikshit R et al (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136:E359\u2013E386","journal-title":"Int J Cancer"},{"key":"1152_CR2","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1007\/s00432-012-1219-x","volume":"138","author":"Y Jin","year":"2012","unstructured":"Jin Y, Shi YX, Cai XY et al (2012) Comparison of five cisplatin-based regimens frequently used as the first-line protocols in metastatic nasopharyngeal carcinoma. J Cancer Res Clin 138:1717\u20131725","journal-title":"J Cancer Res Clin"},{"key":"1152_CR3","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1002\/hed.21884","volume":"34","author":"DTT Chua","year":"2012","unstructured":"Chua DTT, Yiu HHY, Seetalarom K et al (2012) Phase II trial of capecitabine plus cisplatin as first-line therapy in patients with metastatic nasopharyngeal cancer. Head Neck 34:1225\u20131230","journal-title":"Head Neck"},{"key":"1152_CR4","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1023\/A:1008390929826","volume":"10","author":"EH Tan","year":"1990","unstructured":"Tan EH, Khoo KS, Wee J et al (1990) Phase II trial of a paclitaxel and carboplatin combination in Asian patients with metastatic nasopharyngeal carcinoma. Ann Oncol 10:235\u2013237","journal-title":"Ann Oncol"},{"key":"1152_CR5","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1093\/annonc\/mdq425","volume":"22","author":"J Ngeow","year":"2011","unstructured":"Ngeow J, Lim WT, Leong SS et al (2011) Docetaxel is effective in heavily pretreated patients with disseminated nasopharyngeal carcinoma. Ann Oncol 22:718\u2013722","journal-title":"Ann Oncol"},{"key":"1152_CR6","doi-asserted-by":"crossref","unstructured":"Poon D, Chowbay B, Cheung YB et al (2005) Phase II study of irinotecan (CPT-11) as salvage therapy for advanced nasopharyngeal carcinoma. Cancer 103:576\u2013581","DOI":"10.1002\/cncr.20802"},{"key":"1152_CR7","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S1368-8375(02)00120-3","volume":"39","author":"DTT Chua","year":"2003","unstructured":"Chua DTT, Sham JST, Au GKH et al (2003) A phase II study of capecitabine in patients with recurrent and metastatic nasopharyngeal carcinoma pretreated with platinum-based chemotherapy. Oral Oncol 39:361\u2013366","journal-title":"Oral Oncol"},{"key":"1152_CR8","doi-asserted-by":"crossref","unstructured":"Catimel G, Vermorken JB, Clavel M et al (1994) A phase II study of gemcitabine (LY 188011) in patients with advanced squamous cell carcinoma of the head and neck. EORTC Early Clinical Trials Group. Ann Oncol 5:543\u2013547","DOI":"10.1093\/oxfordjournals.annonc.a058910"},{"key":"1152_CR9","doi-asserted-by":"crossref","unstructured":"Zhang L, Huang Y, Hong S et al (2016) Gemcitabine plus cisplatin versus fluorouracil plus cisplatin in recurrent or metastatic nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 trial. Lancet 388:1883-1892","DOI":"10.1016\/S0140-6736(16)31388-5"},{"key":"1152_CR10","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1093\/annonc\/mdf002","volume":"13","author":"KF Foo","year":"2002","unstructured":"Foo KF, Tan EH, Leong SS et al (2002) Gemcitabine in metastatic nasopharyngeal carcinoma of the undifferentiated type. Ann Oncol 13:150\u2013156","journal-title":"Ann Oncol"},{"key":"1152_CR11","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s00280-007-0441-8","volume":"61","author":"L Zhang","year":"2008","unstructured":"Zhang L, Zhang Y, Huang PY et al (2008) Phase II clinical study of gemcitabine in the treatment of patients with advanced nasopharyngeal carcinoma after the failure of platinum-based chemotherapy. Cancer Chemoth Pharm 61:33\u201338","journal-title":"Cancer Chemoth Pharm"},{"key":"1152_CR12","volume-title":"UICC TNM classification of malignant tumours","author":"LH Sobin","year":"2009","unstructured":"Sobin LH, Gospodarowicz MK, Wittekind CH (2009) UICC TNM classification of malignant tumours, 7th edn. Wiley, New York","edition":"7"},{"key":"1152_CR13","doi-asserted-by":"crossref","first-page":"405917","DOI":"10.1155\/2012\/405917","volume":"2012","author":"O Kaidar-Person","year":"2012","unstructured":"Kaidar-Person O, Kuten J, Atrash F et al (2012) Brain metastasis of nasopharyngeal carcinoma: a case report and literature review. Case Rep Med 2012:405917","journal-title":"Case Rep Med"},{"key":"1152_CR14","doi-asserted-by":"crossref","first-page":"82","DOI":"10.4103\/2152-7806.99172","volume":"3","author":"JM Sarmiento","year":"2012","unstructured":"Sarmiento JM, Wi MS, Piao Z et al (2012) Solitary cerebral metastasis from transitional cell carcinoma after a 14-year remission of urinary bladder cancer treated with gemcitabine: case report and literature review. Surg Neurol Int 3:82","journal-title":"Surg Neurol Int"},{"key":"1152_CR15","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1200\/JCO.1999.17.7.2081","volume":"17","author":"L Crino","year":"1999","unstructured":"Crino L, Mosconi AM, Scagliotti G et al (1999) Gemcitabine as second-line treatment for advanced non-small-cell lung cancer: a phase II trial. J Clin Oncol 17:2081\u20132085","journal-title":"J Clin Oncol"},{"key":"1152_CR16","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.oraloncology.2009.12.007","volume":"46","author":"HW Lee","year":"2010","unstructured":"Lee HW, Hwang YH, Han JH et al (2010) High expression of excision repair cross-complementation group1 protein predicts poor outcome in patients with nasopharyngeal cancer. Oral Oncol 46:209\u2013213","journal-title":"Oral Oncol"}],"container-title":["International Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10147-017-1152-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-017-1152-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-017-1152-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,11,7]],"date-time":"2017-11-07T17:08:59Z","timestamp":1510074539000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10147-017-1152-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,14]]},"references-count":16,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["1152"],"URL":"https:\/\/doi.org\/10.1007\/s10147-017-1152-8","relation":{},"ISSN":["1341-9625","1437-7772"],"issn-type":[{"value":"1341-9625","type":"print"},{"value":"1437-7772","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,14]]}}}